|
|
Volumn 81, Issue 1, 1999, Pages 106-108
|
|
Angiotensin-converting enzyme inhibitors but not angiotensin II AT 1 receptor antagonists affect erythropoiesis in patients with anemia of end-stage renal disease [1]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALBUMIN;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
C REACTIVE PROTEIN;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FERRITIN;
IRON;
LOSARTAN;
PARATHYROID HORMONE;
RECOMBINANT ERYTHROPOIETIN;
SOMATOMEDIN C;
TRANSFERRIN;
ADULT;
AGED;
ANEMIA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
ERYTHROPOIESIS;
FEMALE;
HEART FAILURE;
HEMATOCRIT;
HEMODIALYSIS;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY FAILURE;
KIDNEY GRAFT;
LETTER;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RENOVASCULAR HYPERTENSION;
ANEMIA;
ANGIOTENSIN II;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CAPTOPRIL;
ERYTHROPOIESIS;
FEMALE;
HUMANS;
KIDNEY FAILURE, CHRONIC;
LOSARTAN;
MALE;
MIDDLE AGED;
RECEPTORS, ANGIOTENSIN;
|
|
EID: 0032917369
PISSN: 00282766
EISSN: None
Source Type: Journal
DOI: 10.1159/000045257 Document Type: Letter |
|
Times cited : (31)
|
|
References (4)
|
